Investing in health. Social investment package. Commission staff working document. SWD (2013) 43 final, 20 February 2013 by unknown
 
EN     EN 
 
 
EUROPEAN 
COMMISSION 
 
Brussels, 20.2.2013  
SWD(2013) 43 final 
  
SOCIAL INVESTMENT PACKAGE 
COMMISSION STAFF WORKING DOCUMENT 
Investing in Health 
Accompanying the document 
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN 
PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL 
COMMITTEE AND THE COMMITTEE OF THE REGIONS 
 
Towards Social Investment for Growth and Cohesion - including implementing the 
European Social Fund 2014-2020 
{COM(2013) 83 final} 
{SWD(2013) 38 final} 
{SWD(2013) 39 final} 
{SWD(2013) 40 final} 
{SWD(2013) 41 final} 
{SWD(2013) 42 final} 
{SWD(2013) 44 final}   
1 
 
Introduction 
 
 
This document complements the Commission Communication Towards Social Investment for Growth 
and Cohesion by showing how investing in health contributes to the Europe 2020 objective of smart, 
sustainable and inclusive growth.
1 
In line with that Communication, it advocates evaluating and modernising current social policies to 
optimise their effectiveness and efficiency. It also highlights the need for better targeted, 
individualised and integrated services and benefits. It looks at how health is incorporated into the main 
themes of the Communication: making efficiency gains in budgets, taking action throughout life, 
ensuring adequate livelihoods, activating and enabling policies, optimising social dividends and using 
EU funds. 
It also follows on from the 2013 Annual Growth Survey (AGS)
2 which recognises the contribution of 
the healthcare sector to prepare a job-rich recovery. The AGS also acknowledges the sector’s role in 
promoting social inclusion and tackling poverty and recognises the positive effect modernising its 
public administration would have. It recommends reforming health systems to ensure their cost-
effectiveness and sustainability and assessing their performance against the twin aims of providing 
access to high-quality healthcare and using public resources more efficiently. 
This document establishes the role of health as part of the Europe 2020 policy framework. It 
strengthens the link between European health policies and support for health system reforms in the 
context of the European Semester. Investing in health helps the EU rise to the challenges identified in 
its Health Strategy
3 that have been compounded by the economic crisis: an ageing population, an 
increase in chronic diseases, a greater demand for healthcare and the high cost of technological 
progress.   
Health is a value in itself.
4  It is also a precondition for economic prosperity. People’s health 
influences economic outcomes in terms of productivity, labour supply, human capital and public 
spending. 
Health expenditure is recognised as growth-friendly expenditure. Cost-effective and efficient 
health expenditure can increase the quantity and the productivity of labour by increasing healthy life 
                                                            
1 Commission Communication, Europe 2020 Strategy — COM(2010) 2020, 3.3.2010. 
2 Commission Communication, Annual Growth Survey 2013 — COM(2012) 750 final, 28.11.2012 . 
3 Commission White Paper ‘Together for Health: A Strategic Approach for the EU 2008-2013’ COM(2007) 
630 final, 23.10.2007. 
4 Council Conclusions on Common Values and Principles in European Union Health Systems, OJ 2006/C 
146/01, 22.6.2006.  
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expectancy.
5   However, the relatively large share of healthcare spending in total government 
expenditure, combined with the need for budgetary consolidation across the EU, requires more 
efficiency and cost-effectiveness to ensure the sustainability of current health system models. 
Evidence suggests there is considerable potential for efficiency gains in the healthcare sector. 
Average levels of health have been improving across the EU for many years. But this hides major 
inequalities. Poorer and disadvantaged people die younger and suffer more often from disability and 
disease. 
In the following sections, ‘investing in health’ is further developed. 
1. Investing in sustainable health systems combines innovative reforms aimed at improving cost-
efficiency and reconciling fiscal consolidation targets with the continued provision of sufficient levels 
of public services. 
2. Investing in people’s health as human capital helps improve the health of the population in 
general and reinforces employability, thus making active employment policies more effective, helping 
to secure adequate livelihoods and contributing to growth. 
3. Investing in reducing health inequalities contributes to social cohesion and breaks the vicious 
spiral of poor health contributing to, and resulting from, poverty and exclusion. 
4. Investing in health through adequate support from EU funds. 
1. Investing in sustainable health systems: Reform and Innovation 
Health systems in Europe are at the core of its high level of social protection and they are a 
cornerstone of the European social market economy.  The healthcare sector accounts for 8 % of the 
total European workforce and for 10 % of the EU’s GDP.
6 The large share of healthcare costs in the 
EU raises the issue of cost-effectiveness and the financial sustainability of health systems. The 
problems caused by the economic crisis, coupled with more structural changes in demography and the 
types of diseases affecting populations in Europe, reinforce the necessity to reform and modernise 
those systems. The EU can help Member States do so, to improve cost-efficiency through sound 
innovation and contribute to a better assessment of the performance of health systems. 
1.1.   Sustainability of health systems 
Health is an important part of public budgets. It represents almost a third of social policy budgets. 
Public expenditure accounts for almost 80 % of healthcare budgets. In 2010, public spending on 
healthcare accounted for almost 15 % of all government expenditure. In the decade before the crisis, it 
                                                            
5  Commission, Directorate-General for Economic and Financial Affairs (2012), The Quality of Public 
Expenditures in the EU, European Economy, Occasional Papers 125, December 2012 
http://ec.europa.eu/economy_finance/publications/occasional_paper/2012/pdf/ocp125_en.pdf . 
6 Its size varies widely between Member States: above 11 % of GDP in Austria, Denmark, France, Germany 
and the Netherlands; below 7 % of GDP in Estonia, Latvia and Romania.  
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was one of the fastest growing spending items for governments in almost all Member States,
7 
considerably outpacing GDP growth. Public expenditure on healthcare and long-term care is expected 
to increase by one third by 2060. This is due to a number of factors. On the demand side, it is chiefly 
due to population size and structure, its health status, individual and national incomes and provisions 
regulating access to healthcare goods and services. On the supply side, the increase is driven by the 
availability of and distance from health services, technological progress and the framework regulating 
the provision of goods and services.
8 The relatively large share of public healthcare spending in total 
government expenditure, combined with the need to consolidate government budget balances across 
the EU, underscore the need to improve the sustainability of current health system models. Ensuring 
efficiency and making the provision of health services more cost-effective and efficient is crucial if 
countries are to ensure universal access to and equity in health services and their adequate and 
sustainable financing.
9 It is therefore essential to address the financial sustainability of health systems 
to ensure they are sustainable in terms of continuity of service, universal coverage and a high level of 
quality. 
Financial sustainability may require budgetary cuts, including cuts in healthcare budgets. 
Several Member States also need to curtail health costs in the short term. As part of policy responses 
to the economic crisis between 2007 and 2011,
10  some Member States reduced their healthcare 
budgets: Bulgaria, Estonia, Hungary, Ireland, Italy, Greece, Latvia, Romania, Portugal and Spain. 
However, sudden significant reductions in healthcare budgets risk creating new inefficiencies, 
undermining access to and the quality of care, damaging health outcomes and ultimately jeopardising 
the sustainability of the health system even more by increasing costs. A careful assessment of these 
measures should shed light on what policies are effective in the short and long terms. 
Evidence shows that the relationship between healthcare expenditure and health outcomes is not 
linear. If it were, any additional euro spent on healthcare would result in a corresponding 
improvement in the population’s health status (measured, for instance, in terms of healthy life 
expectancy). In reality, the greater the expenditure, the lower the marginal improvement in health 
status as a result of its increase.
11 Countries also vary significantly in their ability to translate a similar 
level of resources into health outcomes. International comparisons show that the same amount of per 
                                                            
7 Health spending grew by nearly 5 % per year in real terms in OECD countries from 2000 to 2009, but this 
was followed by zero growth in 2010, as several countries started implementing budgetary cuts. In fact, 
health spending per capita started declining in 2009 for countries that were hardest hit by the economic crisis 
(OECD Health Data 2012). See  
http://www.oecd.org/document/39/0 3746,en_21571361_44315115_50655591_1_1_1_1.00.html . 
8 Commission-EPC (2012), The 2012 Ageing Report: Economic and budgetary projections for the 27 EU 
Member States (2010-2060). The report projects an increase between 2010 and 2060 of 2.6 % of GDP 
(percentage points) for public expenditure on healthcare and long-term care, a proportional increase of 
around 29.2 % compared to the 2010 reference level of 7.9 % of GDP. See   
http://ec.europa.eu/economy_finance/publications/european_economy/2012/pdf/ee-2012-2_en.pdf. 
9 Directorate-General for Economic and Financial Affairs (2012) The Quality of Public Expenditures in the 
EU, European Economy, Occasional Papers 125, December 2012 
http://ec.europa.eu/economy_finance/publications/occasional_paper/2012/pdf/ocp125_en.pdf. 
10  WHO (2012) Health policy responses to the financial crisis in Europe, WHO Policy Summary 5 
http://www.euro.who.int/__data/assets/pdf_file/0009/170865/e96643.pdf. 
11 See for instance Joumard et al. ‘Health Care Systems: Efficiency and Policy Settings’, OECD, 2010. 
http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=eco/wkp(2010)25&doclanguage=en  
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capita healthcare expenditure can be associated with very different health outcomes even after taking 
into account the differences in lifestyle and socio-economic realities among countries
12. 
It is not only how much money is spent, but also how it is spent, that determines a country’s 
health status. Present budget constraints should therefore be used as an opportunity to improve the 
value and effectiveness of healthcare spending.
13 Health system reforms and improvements in the 
relative allocation of money can contain public spending and could result in large savings. The OECD 
has valued these savings at 2 % of GDP on average by 2017 for OECD countries.
14  
At EU level, the Council has recognised the need to tackle these economic and budgetary difficulties 
by reforming health systems, while balancing the need to provide universal healthcare
15 and  take 
account of their implications in all relevant fields of EU economic policy coordination.
16 
1.2.   Helping Member States design reforms and improving the efficiency 
of health systems 
Comparative international analysis shows that there is significant room for efficiency gains in health 
systems.
17 The Council has confirmed this, noting that in many Member States there appears to be 
scope to improve the population’s health status without increasing health spending.
18 Member States 
should try to reap those gains by introducing efficiency-enhancing measures as part of the overall 
prioritisation and evaluation of public expenditure and in the context of the European Semester. This 
would help reconcile financial consolidation targets with the continued provision of sufficient levels of 
public services. 
The Commission and the Economic Policy Committee identified a number of areas where structural 
reforms and efficiency gains could improve the sustainability of health systems:
19 
                                                            
12 See for instance Joumard I., Andre, C. and C, Nicq, ‘Health care systems - efficiency and institutions’, 
OECD, 2010, Working Paper No. 769. http://www.oecd.org/eco/economicsdepartmentworkingpapers.htm  
13 Better implementation of policies could also result in large savings, as fraud and avoidable errors are 
estimated to represent an annual loss of 5.6 % for healthcare budgets. See European Healthcare Fraud and 
Corruption Network (2009) ‘The financial cost of Healthcare fraud’ 
http://www.ehfcn.org/media/documents/The-Financial-Cost-of-Healthcare-Fraud---Final-(2).pdf. 
Please note that the savings achieved through better implementation are not additional to the figure on 
potential savings given below. 
14 OECD, Economics Department IMF conference, 21 June 2011 ‘Public Health Care Reforms: Challenges 
and Lessons for Advanced and Emerging Europe. See: 
http://www.imf.org/external/np/seminars/eng/2011/paris/pdf/Joumard.pdf. 
15 Council Conclusions on the Joint Report on Health Systems in the EU, 3054
th Council meeting, Economic 
and Financial affairs, 7.12.2010. 
16  Council Conclusions on the sustainability of public finances in the light of ageing populations, 3167 
Council Meeting, Economic and Financial Affairs, 15.5.2012. 
17  Commission, Directorate-General for Economic and Financial Affairs (2012) The Quality of Public 
Expenditures in the EU, European Economy, Occasional Papers 125, December 2012. 
18 Council Conclusions on the Joint Report on Health Systems in the EU, 3054th Council meeting, Economic 
and Financial Affairs, 7.12.2010. 
19  Joint Report on health systems prepared by the European Commission and the Economic Policy 
Committee, European Economy. Occasional Papers. 74. December 2010; and 3054th Council meeting 
Economic and Financial Affairs Brussels, 7.12.2010.  
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o  encouraging more cost-effective provision and use of health services through 
adequate incentives; this could involve 
  using financial incentives to encourage patients to register with a general 
practitioner (GP) or family doctor and using a referral system
20 to define a 
cost-effective path of care: from GP, to outpatient specialist, to hospital, to 
emergency care, while encouraging patients to have less recourse to 
unnecessary care and emergency services; 
  introducing activity- and/or quality-based payment for diagnosis-related 
groups of cases or for hospital financing that, for example, increases the use 
of day surgery instead of in-patient surgery when this is not necessary; 
o  ensuring a balanced mix of staff skills and anticipating staff needs due to ageing; this 
could include 
  improving staff motivation through non-financial aspects (working 
conditions, career advancement etc.) and encouraging continuous professional 
development; 
  addressing the uneven distribution of health staff across regions and 
developing human resources planning mechanisms to address skill mix 
shortcomings
21 (see Section 2.1 on employment in the health sector); 
o  reducing the unnecessary use of specialist and hospital care while improving 
primary healthcare services; improving access to primary care for certain population 
groups could include increasing the number of training posts and making general 
practice more attractive or developing new roles for other healthcare providers, such 
as advanced practice nurses, and encouraging the relocation of general practitioners to 
areas where there is a shortage of them;
22 
o  better health promotion and disease prevention in and outside the health sector; 
this could include measures designed and implemented jointly with other sectors that 
have a major impact on health, such as education, housing, environment, 
                                                            
20 It is generally accepted, especially in recent years, that strengthening primary healthcare can help improve 
the equity, efficiency, effectiveness, and responsiveness of health systems. Most studies analysing the 
transfer of some services from secondary to primary care showed that primary care was more cost-effective. 
Evidence suggests (Fujisawa R. and Lafortune G., 2008, OECD) that in most countries the remuneration of 
specialists is higher than that of GPs. The share of GPs as a percentage of all practising physicians varies 
considerably across the EU, from 49 % in France to 7 % in Greece and Poland, with an EU average of 29 % in 
2006–07 and nine Member States where GPs constitute less than 20 % of all doctors (Bulgaria, the Czech 
Republic, Greece, Latvia, Lithuania, Poland, Portugal, Slovakia and Sweden). This may be relevant for 
countries wishing to implement a primary care-led system with a referral system from primary to specialist 
and hospital care. 
21 Most countries with a relatively low number or uneven distribution of GPs have recognised the problem 
and increased the number of GPs in the last two decades. Despite an increase in the number of practising 
nurses in almost all Member States, except Lithuania and Slovakia, the ratio of nurses to physicians still 
varies widely, from four or more nurses per physician in Denmark, Finland, Ireland, the Netherlands and 
Luxembourg to less than one in Italy or Greece. Commission-OECD, Health at a glance: Europe 2012; 
http://ec.europa.eu/health/reports/docs/health_glance_2012_en.pdf. 
22 Ibid.  
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employment
23   (see Section 2.3 on health promotion and Section 3 on health 
inequalities); 
o  improving data collection and using available information to underpin the 
improvement of the performance of health systems; in particular the collection of 
health data using the European Community Health Indicators (ECHI) and developing 
tools to better assess the efficiency of health systems (see Section 1.4 on health 
systems performance assessment); 
o  using health technology assessment more systematically for decision-making 
processes (see Section 1.3 on health technology assessment); 
o  ensuring the cost-effective use of medicines; this includes increasing the use of less 
expensive equivalent (generic) drugs
24 for example through pricing measures (price 
limit, lower cost-sharing rate), their prescription, or facilitating their access to the 
market, as well as improving the assessment of the effectiveness and cost-
effectiveness of medicines in general and better informing patients, healthcare staff 
and insurers about their use and misuse; 
The recommendations above from the Commission/EPC report of 2010 are consistent with the WHO’s 
‘ten leading sources of inefficiency of health systems’
25 and the OECD’s recommendations for health 
system reform.
26 
Health system reform is also addressed: 
•  As part of the European Semester, Member States have started to include health systems 
reform in their National Reform Programmes.
27 Following the 2012 Annual Growth Survey,
28 
six country-specific recommendations on health
 29  were issued for Austria (implementing 
reforms to improve the organisation, financing and efficiency of healthcare), Belgium 
(improving the long-term sustainability of public finances by curbing age-related expenditure, 
including health expenditure), Bulgaria (doing more to improve the quality of public spending, 
particularly in the education and health sectors), Cyprus (completing and implementing the 
national health system), Germany (continuing growth-friendly consolidation by doing more to 
                                                            
 
23 For an economic valuation of the health impact of social welfare spending and mortality, see D. Stuckler, 
S. Basu. M. McKee; Budget Crisis, Health and Social Welfare Programmes; BMJ 2010, 340. 
24 A recent study on forecasting EU pharmaceutical expenditure shows a consistent reduction (between 2 % 
and 10 % depending on the country) in pharmaceutical expenditure in six (France, Germany, Greece, 
Hungary, Portugal and the United Kingdom) out of seven countries studied (with the exception of Poland). 
The study concludes that the best ways of reducing pharmaceutical budgets are reducing generic prices, 
distributing biosimilars through the hospital chain and increasing the number of generic medicines. 
25 WHO, The World Health Report — Health systems financing: the path to universal coverage (2010). 
http://www.who.int/whr/2010/whr10_en.pdf. 
26 The OECD has identified several system-level reforms: providing comparative performance indication, 
reforming provider payment mechanisms, improving the patient’s choice and provider competition, giving 
guidelines on good practice and target, audit and inspection systems. OECD, Achieving better value for 
money in healthcare (2009) and health ministerial meeting, 7-8 October 2010. See also Smith Peter C. What 
is the scope for health system efficiency gains to be achieved?, Eurohealth incorporating Euro Observer — 
vol.18, No 3 (2012). 
27 http://ec.europa.eu/economy_finance/economic_governance/sgp/convergence/programmes/2012_en.htm. 
28  Commission Communication, Annual Growth Survey 2012 — COM(2011) 815 final, 23.11.2011. 
http://ec.europa.eu/europe2020/pdf/ags2012_en.pdf. 
29 http://ec.europa.eu/europe2020/making-it-happen/country-specific-recommendations/index_en.htm.  
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improve the efficiency of public spending on healthcare and long-term care) and the 
Netherlands (implementing the planned reform of long-term care, aimed at separating the 
costs of medical care from the costs of assisted living, and complementing it with other 
measures to contain the increase in costs). The 2013 Annual Growth Survey recommends 
reforming health systems to ensure their cost-effectiveness and sustainability and assessing 
their performance against the twin aims of providing access to high-quality healthcare and 
using public resources more efficiently.
30 
•  In a reflection process as a follow-up to Council conclusions of 2010, Member States are 
currently identifying effective ways of investing in health for modern, responsive and 
sustainable health systems. In this context, by the end of 2013, conclusions will be drawn on 
the following  areas of focus of the reflection process: health in the context of the Europe 2020 
Strategy and the European Semester; success factors for the effective use of Structural Funds 
for health investments; responses to health system challenges, in particular in relation to 
integrated care and the use of pharmaceuticals; measuring and monitoring the effectiveness of 
health investments.
31  
To support these processes, the Commission is setting up a multisectoral, independent expert panel to 
advise on effective ways of investing in health
32  and commissioned a number of studies on 
forecasting EU pharmaceutical expenditure,
33   external reference pricing of medicinal products, 
reimbursement systems of medicinal products, the economics of primary healthcare financing and the 
evaluation of public-private partnerships in healthcare delivery.
34  
 
1.3.   Improving cost-efficiency through sound innovation 
 
New  technologies are widely acknowledged as an important tool for boosting innovation. 
Technological developments can change ways of delivering and organising the provision of health 
services and goods and, under certain conditions, help increase cost-efficiency. They can however be 
expensive to buy and operate and may be used inappropriately. Innovations in medical technology are 
considered one of the primary drivers of healthcare spending. The introduction of innovative 
                                                            
30 Commission Communication, Annual Growth Survey 2013 — COM(2012) 750 final, 28.11.2012, and 
thematic summary on health and healthcare systems relevant for the Europe 2020 Strategy: 
http://ec.europa.eu/europe2020/making-it-happen/key-areas/index_en.htm. 
31 Council Conclusions: Towards modern, responsive and sustainable health systems, 3095 Employment, 
Social Policy, Health and Consumer Affairs Council meeting, Luxembourg, 6. 6.2011. This process started in 
2011 under the auspices of the Working Party on Public Health at Senior Level and is expected to end at the 
end of 2013. 
32 Commission Decision 2012/C 198/06 of 5 July 2012 on setting up a multisectoral and independent expert 
panel to provide advice on effective ways of investing in health. 
33 Creativ-Ceutical (2012), EU Pharmaceutical expenditure forecast, final report 26 November 2012. 
http://ec.europa.eu/health/healthcare/docs/creativ_ceutical_eu_pharmaceutical_expenditure_forecast.pdf. 
34 As envisaged in the 2013 work plan of the Health Programme, Commission implementing decision of 28 
November 2012 concerning the adoption of the 2013 work plan (2012/C — 378/07). The results of these 
studies financed by the EU Health programme are expected to become available in the course of 2014.  
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technological solutions should therefore be thoroughly assessed in terms of their potential to improve 
efficiency and productivity.
35 
Health Technology Assessment (HTA) is the main tool developed to assess and support the cost-
effective use of new technologies and innovation in healthcare.
36  It is a multidisciplinary process 
firmly rooted in research and the scientific method that summarises information about the medical, 
social, economic and ethical issues related to the use of a health technology in a systematic, 
transparent and unbiased manner. It is an essential tool for informing decision-makers and assessing 
the value of specific actions or technologies, thus reducing the risk of implementing measures that 
negatively affect patient outcomes. 
At EU level, the Commission has been helping Member States exploit the full potential of HTA by 
fostering cooperation that will pool expertise and prevent the duplication of work as set out in the 
Directive on the application of patients’ rights in cross-border healthcare, through the European network 
for health technology assessment.
37  
Health Technology Assessment examples 
In Austria and Norway, Health Technology Assessment was used to assess the introduction of the 
HPV vaccine in national vaccination programmes. Although the two countries had similar views on 
the effectiveness of the measure, other context-specific considerations, such as different cost 
considerations, led to different decisions regarding uptake. 
In the UK, the National Institute for Health and Clinical Excellence (NICE) issues recommendations 
based on HTA. One such recommendation is based on the comparison of different medicinal products 
used as the primary way of preventing osteoporosis. This kind of report provides guidance on what 
products would be the preferred choice in different settings, based on a cost-effectiveness analysis. It 
thus serves as guidance for general practitioners in their practice, helping to avoid unnecessary, costly 
treatments. 
In Poland, the Agency for Health Technology Assessment (AHTAPol) was established in 2005 as an 
advisory body to the Ministry of Health. It prepares recommendations on financing all healthcare 
services from public funds, notably on the drug reimbursement list (available in pharmacies); 
therapeutic drugs programmes (expensive, innovative drugs) and the hospital chemotherapy drug 
reimbursement list; non-drug technologies (medical devices, surgical procedures etc.); national and 
local government healthcare programmes. This allows for a more holistic approach to the use of 
limited public health budgets, taking the cost-effectiveness of different treatments into account. 
 
                                                            
35 EC-EPC (2012), The 2012 Ageing Report: Economic and budgetary projections for the 27 EU Member 
States (2010-2060). 
36 Health technology means a medicinal product, a medical device or medical and surgical procedures as well 
as measures for disease prevention, diagnosis or treatment used in healthcare. 
37 Directive 2011/24/EU of 9 March 2011 on the application of patients’ rights in cross-border healthcare — 
in particular Article 15. This is mainly realised through the European network for health technology 
assessment. See http://ec.europa.eu/health/technology_assessment/policy/index_en.htm  
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E-health covers the range of tools that can be used to assist and enhance prevention, diagnosis, 
treatment, monitoring and management concerning health and lifestyle. It is often perceived as 
substantially increasing productivity, and therefore as an instrument to support the reform of health 
systems. Examples of successful e-health developments include health information management and 
networks, electronic health records, telemedicine services, wearable and portable monitoring systems 
and health portals. Developing and deploying new technologies is a long-term endeavour. European 
research programmes have been supporting the development of e-health for the last 15 years. They 
have established a number of best practices that could be successfully replicated, for example e-health 
applications improving quality of life and reducing hospitalisation to the benefit of citizens, their 
families and those involved in providing services.
38 Support for the interoperability of health systems 
within and across national boundaries will improve the mobility and the safety of patients even more 
by ensuring continuity of care and innovation. 
The Commission also contributes to e-health through a range of actions and instruments, such as the 
Action Plan on e-Health
39 and the newly created EU e-Health Network, as part of the implementation 
of the Directive on the application of patients’ rights in cross-border healthcare.
40  
E-health project example 
The delivery of e-prescriptions in Sweden is a joint initiative between each county council and 
Apoteket, Sweden’s national pharmacy. Via Sjunet, the Swedish Information and Communication 
Technologies (ICT) network for healthcare, or using web-based prescriptions, 42 % of all prescriptions 
are electronically transferred from the doctor to the pharmacy. E-prescriptions increased the security 
and quality of prescriptions and reduced medication errors by 15 %. They also enabled healthcare 
providers to save a lot of time. Patients benefited from a dedicated drug information hotline which 
improved their knowledge and safety and their flexibility to obtain their drugs in any pharmacy. The 
economic evaluation of the case-study on e-prescriptions in the Stockholm region showed that this 
electronic service generated an estimated annual net economic benefit of over € 95 m in the eight years 
of its implementation. Five years after planning and development began, the net benefit was 
approximately € 27 m. This is impressive, given the relatively low spending on ICT of less than € 4 m 
for the whole period of eight years. Healthcare provider organisations get 80 % of the benefits, mainly 
from time savings and avoided costs of providing the same timeliness, convenience and reduction in 
errors without e-health. Citizens get the remaining 20 %, chiefly through more safety thanks to 
correctly issued prescriptions and better adherence to treatment.
41 
1.4.   Developing tools to better assess the efficiency of health systems 
Increasing the return on health investments requires a solid assessment of the efficiency and 
effectiveness of spending. Such an assessment faces three main methodological challenges. 
                                                            
38 See in particular Lluch, M. (2012), Evidence consolidation — Report on best practices and key drivers of 
success, SIMPHS2, Luxembourg, JRC (European Commission).   
http://is.jrc.ec.europa.eu/pages/TFS/documents/SIMPHS2D4.1FinalReportonEvidenceConsolidationrev2acc.
pdf. 
39 See http://ec.europa.eu/information_society/activities/health/policy/index_en.htm. 
40 Directive 2011/24/EU of 9 March 2011 on the application of patients’ rights in cross-border healthcare. 
41 E-health is Worth it. The economic benefits of implemented e-health solutions at ten European sites. Karl 
A. Stroetmann, Tom Jones, Alexander Dobrev, Veli N. Stroetmann, 2006.  
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The first is to verify that the evidence of efficiency gains and improvements in health obtained through 
better use of healthcare budgets remains valid when different definitions of health outcomes are 
used.
42 A major problem is that much of the evidence focuses on crude measurements such as life 
expectancy, failing to consider the quality of the years of life gained. This is more clearly brought out 
by concepts such as Disability Adjusted Life Years (DALY), or Healthy Life Years (HLY). 
The second challenge is to disentangle the relative influence of health systems on health outcomes 
from the impact of other determinants of population health, especially living and working conditions, 
income, education and the most common lifestyle-related risk factors 
The third is the time lags between policy changes and their impact on health outcomes,
43 a problem 
that may involve ‘false savings’ because they may lead to increased costs or other unintended 
consequences in the long term. 
Further assessment of the efficiency of health systems therefore requires a refined analytical 
framework, structured along three axes: 
(1) the definition of sound, reliable indicator(s) of health outcomes, building on the existing 
European Community Health Indicators, 
(2) a better understanding of the effects of health systems on health outcomes, as distinct from the 
impacts on health of other factors such as health determinants and lifestyles, and 
(3) a better understanding of the mechanisms, and therefore the timing, of how health policies 
affect health outcomes. 
The Commission will continue to support the work of Member States by improving the knowledge 
and evidence on health expenditure and health outcomes in the achievement of structural reforms. It 
will do so by working towards a sustainable health monitoring system in Europe, using the European 
Community Health Indicators (ECHI),
44 by developing a sound methodology for Health System 
Performance Assessment and by assessing the cost-effectiveness of health systems through Life 
Table Analysis. It will also do more to provide much-needed information on the breakdown of 
expenditure per disease in the EU.
45 
 
 
                                                            
42   OECD (2008). ‘Health Status Determinants: Lifestyle, Environment, HealthCare Resources and 
Efficiency,’ OECD Economics Department Working Papers 627. 
43 See Philipa Mladovsky, Divya Srivastava, Jonathan Cylus, Marina Karanikolos, Tamás Evetovits, Sarah 
Thomson, Martin McKee, Health policy responses to the financial crisis in Europe, WHO Policy Summary 5 
http://www.euro.who.int/__data/assets/pdf_file/0009/170865/e96643.pdf. 
44 A shortlist of 88 European Community Health Indicators (ECHI) has been developed under different EU 
Health Programmes and now provides a health monitoring system at EU level. It covers all aspects of health: 
health status, health determinants, healthcare services, health promotion, demography and socio-economic 
situation. 
45 Actions to be undertaken with the financial support of the Health Programme, Commission implementing 
decision of 28 November 2012 concerning the adoption of the 2013 work plan (2012/C — 378/07).  
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2.  Health as an investment in human capital 
Cost-effective and efficient health spending is a productive or growth-friendly type of 
expenditure. It helps increase the economy’s production assets (labour, capital and knowledge). It 
increases the quantity and the productivity of labour by increasing healthy life expectancy.
46Investing 
in the health of people of working age and enabling people to remain active and in better health for 
longer helps optimise the ‘social dividend’. Investing in health also helps limit future costs related to 
the treatment of preventable diseases. And finally, investing in health also means investing in an 
efficient health workforce
47. 
2.1.   Contributing to employability and enabling people to remain active 
for longer 
The health status of individuals strongly influences their labour market participation. For 
example, early labour market exit is often the result of health-related problems.
48 Depression, 
musculoskeletal diseases and unhealthy lifestyle factors (e.g. obesity and physical inactivity), are 
associated with reduced on-the-job productivity. Evidence suggests that ill-health in the population of 
working age leads to substantial productivity losses.
 Poor health leads to absenteeism (estimated 
absenteeism rates range between 3 % and 6 % of working time, representing a yearly cost of about 
2.5 % of GDP
49), job loss (10 % of the people who were previously employed left their job mainly for 
health reasons), premature retirement or premature mortality. Almost a quarter (23.5 %) of the people 
currently employed suffer from a chronic condition and have their daily activities restricted.
50  
This adverse effect of ill-health is most significant in the later stages of life, when it contributes to a 
marked decrease in participation in the workforce. In 2010, the employment rate of people over 65 
was 4.7 %, that of people aged 60-64 was 30.5 % and that of people aged 55-59 was 60.9 %.
51 Elderly 
people are much more likely to suffer from multiple diseases (co-morbidity). This has significant 
human and economic implications and increases the pressure on health systems and social care 
structures in terms of demand for care
52. 
                                                            
46  Commission, Directorate-General for Economic and Financial Affairs (2012), The Quality of Public 
Expenditures in the EU, European Economy, Occasional Papers 125, December 2012. 
47  Key issues pertaining to the future health workforce are covered in: "Towards a job rich recovery", 
COM(2012) 173 final, notably  in the "Action Plan for the EU Health Workforce", SWD(2012) 93 final. 
48 See for instance various findings from the large-scale Health and Retirement Study project collecting 
personal data in longitudinal follow-up.   
http://hrsonline.isr.umich.edu/sitedocs/databook/HRS_Text_WEB_Ch1.pdf. 
49 EUROFOUND (2010), Absence from work report. 
 http://www.eurofound.europa.eu/ewco/studies/tn0911039s/tn0911039s_5.htm. 
50  The average percentage of productivity loss at work among workers with cardiovascular diseases is 
estimated at 7 %, compared with 15 % on average for workers with depression and 34 % among workers with 
upper extremity disorders,
 Oortwijn et al. (2011), Health of people of working age Report. 
http://ec.europa.eu/health/social_determinants/docs/final_full_ecorys_web.pdf. 
51 While several factors such as pension systems and age-management at work influence employment rates, 
people’s health status also affects their ability to continue working. Commission (2012) data. 
http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-13012012-BP/EN/3-13012012-BP-EN.PDF. 
52 For more details, and notably on the need for long-term care, see the Staff Working Document on "Long-
term care in ageing societies – Challenges and policy options" adopted as part of this package.  
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Longer lives are not lived without disability. Europeans are expected to live on average almost 20 
years with an activity limitation. The levels of healthy life expectancy in the EU are at 62.2 healthy 
life years (HLY) for women and 61 HLY for men,
53  
It is therefore possible to boost economic growth by improving the health status of the population 
and enabling people to remain active and in better health for longer Access to quality health care 
is a constituent part of the maintenance of a productive workforce and an integral part of the 
flexicurity setup
54. There is scope for creating a cycle in which improvements in health and prosperity 
are mutually reinforcing.
55 Improving the population’s health status leads to positive economic 
outcomes. An OECD study estimates that for every year of increase in a population’s life expectancy 
GDP could go up as much as 4 %.
56 Occupational health plays a key role in that context.  
However, the potential benefits from health investments through increased population 
employability are currently not understood well enough. The current cost of occupational accidents 
and work-related diseases amounts to between 2,6-3,8% of EU GDP
57. Poor working conditions 
impact not only on the work-force employability, but also on the sustainability of national healthcare 
systems. By reducing the workers' exposure to risk factors, well-designed OSH-policies increase 
productivity and limit the cost of work-related accidents and ill health.  European regulation and 
strategies  have helped reduce the incidence of accidents  and have played an important role in 
preventing occupational diseases. However, there is a continuous need to improve the workplace 
environment by investing in prevention of accidents and diseases caused by work.  It should also take 
into consideration the economic context of the labour market in question. For example, 
musculoskeletal conditions would have a greater impact on the ability to work and on employability in 
the blue-collar manual jobs industry than in the white-collar service sector. 
One example of a tool to assess the effect of alternative policy outcomes on long-term social 
expenditure is the social expenditure projection model (SOME
58) developed in Finland. Explicit 
consideration is given to the impact of population health and beneficial employment effects. This way, 
future benefits associated with health investments can be better understood. 
 
                                                            
53  Commission-OECD  (2012),  Health at a Glance: Europe 2012, OECD Publishing. 
http://dx.doi.org/10.1787/9789264183896-en. 
54   See "Towards a job rich recovery", COM(2012) 173 final, notably "Open, dynamic and inclusive labour 
markets", SWD(2012) 97 final. 
55 Martin McKee and Marc Suhrcke (2010), Investing in Health: A Contribution to the Achievement of the 
Lisbon Agenda, European Review/Volume 18/Issue 01/February 2010. 
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=6906144. 
56  Bloom, Canning, Sevilla (2004), The Effect of Health on Economic Growth: a production function 
approach, World Development, Vol. 32, No 1 (http://qcpages.qc.cuny.edu/~redwards/GC-Econ71100/bloom-
etal-wd04.pdf). The WHO 2010 Global Report on Non-Communicable Diseases recognises that each 10 % 
rise in NCDs is associated with 0.5 % lower rates of annual economic growth 
(http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf). 
57 https://osha.europa.eu/en/safety-health-in-figures 
58 Ministry of Social Affairs and Health, Finland Social expenditure scenarios — effects of health promotion 
and a presentation of the analysis model, Reports of the Ministry of Social Affairs and Health 2009:7, 13 
February 2009.  
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Health status of individuals and labour market participation: example of diabetes type 2 
A striking example of how prevention can increase labour market participation is the avoidable 
negative effects of diabetes type 2, which currently affects 7 % of Europeans. A French longitudinal 
study
59 found that diabetes type 2 patients lost an estimated mean time of 1.1 year in the workforce 
between the ages of 35 and 60. 
More generally available statistical data
60 seem to show that chronic conditions have an important 
impact on several dimensions of social inclusion. Comparing to a healthy individual, the impact of 
diabetes type 2 for a 50-year old single man is significant. It represents almost 3 % of career lost (in 
terms of years of working life). It also has significant individual consequences, as it shortens the 
lifespan by 2.3 % and increases the chance of being at risk of poverty by more than 5 %. 
Another way to enable people to remain active and in better health for longer is to help people with 
chronic conditions that do not require hospitalisation to function actively in society and at home by 
empowering them to take care of their health in close collaboration with healthcare providers. 
Learning to manage their own condition should help people to remain integrated in society and the 
workforce. 
The idea of patient empowerment is often considered an important and promising aspect of chronic 
disease management, that can help people lead more proactive and fulfilling lives. Some evidence 
suggests that self-management (supported for example by e-health applications
61) can be effective 
through behavioural change, especially for people with long-term conditions. It may improve their 
health status and reduce their drug treatment costs and the time they spend in hospital.
62 
Empowerment should not substitute professional acute care. However, various patient empowerment 
models can be applied. More research needs to be done to assess the efficiency and efficacy of these 
models, and find out how to reach and include specific target groups such as vulnerable populations.   
The European Innovation Partnership (EIP) on Active and Healthy Ageing will help citizens to 
lead healthier, more active and independent lives while ageing. It aims to increase the number of 
healthy life years of Europeans by two years by 2020. It applies an innovative approach to 
policy-making in the EU by bringing together key stakeholders (end users, public authorities, and 
industry) and providing a forum for cooperation, the identification of potential innovation barriers and 
the mobilisation of funding instruments. It aims to improve the framework conditions for the uptake of 
innovation, leveraging financing and investments in innovation and improving coordination and 
                                                            
59 See http://www.hal.inserm.fr/docs/00/59/35/06/PDF/Diabetes_Care_May_2011.pdf. 
60 Sources: Commission data for Poverty Rates, Life Expectancy, Population, GDP, labour market, healthcare 
expenditure. International Diabetes Federation (IDF) for Diabetes Type 2 epidemiology and direct medical 
cost, peer-reviewed journal publications for Quality of Life (QoL). 
61 See Lluch, M. (2012), Evidence consolidation — Report on best practices and key drivers of success, 
SIMPHS2, Luxembourg JRC (European Commission).   Available at   
http://is.jrc.ec.europa.eu/pages/TFS/documents/SIMPHS2D4.1FinalReportonEvidenceConsolidationrev2acc.
pdf. 
62 See Rijken, M., M. Jones, et al. (2008), Supporting self-management. Caring for people with chronic 
conditions: A health system perspective, E. Nolte and M. McKee, Maidenhead, Open University press (in 
cooperation with World Health Organisation 2008 on behalf of the European Observatory on Health Systems 
and Policies).  
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coherence between funding for research and innovation at European, national and regional level in the 
European Union. 
The EIP focuses on the following areas throughout a person’s life: prevention, screening and 
early diagnosis; care and cure; active ageing and independent living. Between now and 2015, 261 
commitments, made by over 3 000 stakeholders and grouped in six action plans, will be implemented, 
focusing on the following:
63  
•  prescription and adherence to treatment; 
•  personal health management, starting with an initiative to prevent old people from falling; 
•  prevention and early diagnosis of functional decline and frailty; 
•  replicating and tutoring integrated care for chronic diseases, including remote monitoring; 
•  developing interoperable independent living solutions, including guidelines for business 
models; and 
•  innovating for age-friendly buildings, cities and environments. 
 
Example of a project developed under the European Innovation Partnership on Active and 
Healthy Ageing — Feelgood Factory Agenda 
This project helps people to monitor their health and receive advice through the television. Results 
show that patients who were in and out of the hospital every week now go to the hospital only once or 
twice a year. 
Liverpool Primary Care Trust (PCT) in the UK is the Feelgood Factory Agenda’s lead partner. Much 
of the focus is on people who are older and have long-term conditions (143 000 in Liverpool). One 
hundred and fifty ‘community health champions’ have been recruited to design packages for people 
with long-term conditions. The packages include lifestyle advice, self-management advice and 
equipment. Voluntary champion roles might motivate people to work in the emergency care sector, or 
up-skill unemployed people. Liverpool PCT will target 50 000 members, 3 500 users of telehealth, 
5 000 users of Life Enhancing Technologies (LETs) and 3 500 users of integrated LETs and social 
services. Financial and human resources allocated to the initiative include a € 21 million programme, 
consisting of a direct financial contribution of € 15.6 million and € 6 million in human resources, 
expertise, the provision of equipment and the use of existing services and infrastructure. 
 
The following areas have proved particularly important in bringing about added value in improving 
cost-effectiveness and efficiency in health care and t the Commission intends to continue to pursue 
action to
64 
•  support  research into the effects of health investments on employability; better 
understanding the relationship between the two could facilitate the identification and exchange 
of good practice; 
                                                            
63   Commission Communication, Taking forward the Strategic Implementation Plan of the European 
Innovation Partnership on Active and Healthy Ageing — COM(2012) 83 final. 
64 Through financing from the Health Programme, Commission implementing decision of 28 November 2012 
concerning the adoption of the 2013 Health Programme work plan (2012/C — 378/07).  
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•  contribute to the practical understanding of patient empowerment and support exchanges 
of experience in this field by launching a mapping of current policies and evidence; such a 
mapping would clarify the scope of patient empowerment and identify potential advantages 
and barriers. 
•  continue to encourage cooperation in the European Innovation Partnership on Active and 
Healthy Ageing. 
 
2.2.   Promoting good health 
 
Tackling the problem of chronic diseases and addressing the main risk factors that determine 
population health will help increase people’s employability and enable them to stay longer in the 
workforce. The human and economic burdens of chronic diseases can be contained by devoting 
resources directly or indirectly to prevention, screening, treatment and care. It is important to do so by 
targeting the different age groups throughout their lives.
65 A large amount of health spending, 
including in particular disease prevention and health promotion, is regarded as an investment 
that yields a handsome rate of return.
66 Focusing on disease prevention can reduce high long-term 
treatment costs and improve health outcomes by avoiding tens of thousands of premature deaths 
and chronic diseases.
67 However, little relative importance is currently given to health promotion in 
budgetary terms. Only about 3 % of current health expenditure is allocated to public health and 
prevention programmes. In other words, most Member States do not use the opportunities for 
substantial gains in prevention and health promotion, particularly through the health-in-all-policies 
approach, which aims to influence the environmental, economic and social determinants of health. 
Given the potential to contain the burden and cost of disease in the long term, the importance given to 
disease prevention and health promotion should be reassessed. 
A recent study
68 showed that evidence-based workplace interventions to promote mental health could 
help save up to € 135 billion a year by reducing absenteeism and early retirement. 
There is a wide array of health promotion and disease prevention measures authorities can and 
should make use of in many different settings (at work, at school and in health institutions). These 
range from public information campaigns in the media, excise taxes on certain products such as 
                                                            
65 Council Conclusions on Healthy Ageing across the Lifecycle, 7.12.2012. 
66 World Economic Forum, Harvard School of Public Health (2011), The Global Economic Burden of Non-
Communicable Diseases. 
67 OECD (2010), ‘Obesity and the economics of prevention: Fit not fat’. 
68 Matrix Insight (2012), ‘Economic analysis of workplace mental health promotion and mental disorder 
prevention programmes and of their potential contributions to EU health, social and economic policy 
objectives — final report’. See also OECD (2011), ‘Sick on the Job. Myths and Realities about Mental 
Health and Work’ and Knapp, McDaid, Parsonage (2011), ‘Mental health promotion and mental disorder 
prevention. The economic case’.  
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tobacco or alcohol, bans and stricter regulation on labelling, advertising and selling, to health 
education on school curricula and financial incentives for consumers, patients and providers.
69  
The World Health Organisation has also identified a number of ‘best buys’ in chronic 
non-communicable disease prevention: incentive fiscal measures, food product reformulation, 
detection and treatment of those at high risk of a heart attack, including early detection and treatment 
of high blood pressure.
70    
The Member States began a reflection process aimed to identify innovative approaches to address 
chronic diseases.
71 This could include setting up best practice mechanisms at EU level to identify, 
validate and disseminate good practice and information on policies  and measures to tackle the 
problem of chronic diseases, including the development of quality control instruments. The reflection 
process on chronic diseases is expected to yield conclusions by the end of 2013.
72  
2.3.  Employment in the health sector 
Investing in health also means investing in the health workforce. The health and social work 
sector
73 has in recent years been the single largest contributor to employment, accounting today for 
about 10 % of employment. The sector also generates high-skilled jobs. Almost 40 % of workers in the 
health and social work sector have tertiary qualifications. This is much higher than the 26 % average 
across all sectors.
74 While the European Union lost more than two and half million jobs between 2008 
and 2011, the sector generated over 2.8 million new jobs during the same period. Population ageing is 
likely to increase that trend. Assuming a constant share of labour in this area, this would mean a 
regular increase of up to eight million job vacancies by 2020,
75 although the impact of health reforms 
and organisational and technological changes on staff needs remains uncertain. The 2013 Annual 
Growth Survey highlights the potential that can be tapped in this sector, through a future-oriented, 
                                                            
69  Joint Report on health systems prepared by the European Commission and the Economic Policy 
Committee, European Economy, Occasional Papers 74, December 2010. 
70   World Health Organisation (2011), ‘Global status report on non communicable diseases’, 
http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf. 
71  Council Conclusions on ‘Innovative approaches for chronic diseases in public health and healthcare 
systems’ Brussels, 7.12.2010. 
72 As foreseen in the 2013 work plan of the Health Programme , this process will be supported by a joint 
action on chronic diseases that will address preventing and delaying the onset of chronic diseases throughout 
the life cycle and aspects of the secondary prevention, screening, early diagnosis, and treatment of diabetes 
type 2, and develop innovative, cost-efficient and patient-centred approaches for the management of patients 
with multiple chronic conditions. 
73 The ‘Health and social work’ sector includes three sub-sectors: ‘human health’, ‘residential care’, and 
‘non-residential social work’. For some statistics no breakdown is available; in order to present comparable 
data it is therefore necessary to present the aggregate value for the whole sector. 
74 Commission services estimate. 
75 The last CEDEFOP skills forecast expects employment to increase by one million between 2010 and 2020. 
Increasing healthcare needs and the ageing of healthcare professionals should result in seven million 
vacancies due to replacement needs. Therefore, together with net employment change, around eight million 
job vacancies in total are projected. See CEDEFOP (2010), Skills supply and demand in Europe Medium-
term forecast up to 2020 and http://www.cedefop.europa.eu/EN/about-cedefop/projects/forecasting-skill-
demand-and-supply/skills-forecasts.aspx.  
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reliable legal framework, the development of adequate skills and targeted, fiscally sustainable public 
support.
76  
Nevertheless, as part of the process of modernising public administration, the possible increase in 
employment in the health and social work sector must be carefully balanced against the 
potential increase in public expenditure on health and overall public expenditure and must not 
compromise the attainment of fiscal sustainability. Future needs related to an ageing population must 
be met by exploiting the extensive margin for efficiency gain and better productivity. 
The Action Plan for the EU health workforce, which is part of the Employment Package of Spring 
2012 "Towards a Job Rich Recovery"
77 supports cooperation to help improve workforce planning and 
forecasting and the recruitment and retention of health professionals. An EU joint action
78 on 
forecasting health workforce needs for effective planning in the EU will create a partnership of 
Member States and professional organisations to share good practice and develop methodologies. 
3. Reducing inequalities in health 
Health outcomes vary considerably within and between Member States. In 2010, the gap in life 
expectancy at birth between the highest and lowest values for EU-27 Member States was 11.6 years 
for males and 7.9 years for females. People with a lower income and less education die younger and 
their health is worse. For example, differences in life expectancy at age 30 between those in higher 
education and those with basic secondary education or less exceed 10 years in many Member States.
79 
Across the EU the level of disability, in terms of reported restrictions on daily living activities, is more 
than twice as high in the lowest income quintile as in the highest income quintile.
80 Even larger 
health inequalities exist for some vulnerable groups such as some ethnic minorities (Roma) and 
some migrant groups. 
These health inequalities represent not only a waste of human potential, but also a huge 
potential economic loss — conservatively estimated at between 1.5 % and 9.5 % of GDP according to 
a report written for the Commission.
81    
Reasons for these differences include barriers in access to healthcare, which is often worse for 
disadvantaged groups/ persons in vulnerable situations
82 and in less wealthy Member States,
83 as 
                                                            
76 Commission Communication, Annual Growth Survey 2013 — COM(2012) 750 final, 28.11.2012. 
77 Commission Staff Working Document on an Action Plan for the EU Health Workforce — SWD(2012) 93 
final attached to the Commission Communication, Towards a Job Rich Recovery — COM(2012) 173 final, 
April 2012. 
78 To be financed by the EU Health programme, see Commission Implementing Decision of 28 November 
2012 on the Health programme work plan for 2013 (2011/C/ 358/06). 
79 Eurostat statistics in focus 24/2010. 
80 EU Statistics on Income and Living Conditions. 
81 Economic implications of socio-economic inequalities in health in the European Union, Mackenbach J, 
Meerding W, Kunst A., Directorate-General for Health and Consumers 2007.  
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well as poorer diets, housing, living and working conditions, and higher levels of health-damaging 
behaviours. The impact of the current crisis on these factors threatens to increase health inequalities 
between social groups and between Member States. 
As stated in the 2013 AGS, ‘additional efforts are needed to ensure the effectiveness of social 
protection systems in countering the effects of the crisis, to promote social inclusion and to prevent 
poverty’, including by providing broad access to affordable, high-quality health services.
84 
Investments to reduce inequalities in health should therefore also make a positive contribution 
towards reaching the Europe 2020 poverty and social exclusion target. 
A multisectoral approach is required, with a focus on achieving greater gains in less advantaged 
groups than the average in order to close gaps.
85 Key measures are to prioritise less advantaged groups 
in policies to improve the quality of and access to health systems, to address the underlying risk 
factors in health behaviours and to ensure adequate incomes and living and working conditions.
86 Such 
measures are underpinned by the fundamental values and commitments the EU and its Member States 
have agreed on with regard to human rights, equal opportunities, social and economic cohesion and 
solidarity. Specific EU action on health inequalities is set out in the 2009 Commission 
Communication on health inequalities,  Solidarity in Health. A progress report on the health 
inequalities situation and the actions set out in the Communication will be published in 2013. 
Data on the effects of social transfers on the at-risk-of-poverty rate suggests that healthcare plays a 
significant role in reducing the at-risk-of-poverty rate. Access to affordable healthcare is therefore 
necessary for adequate livelihoods. Fiscal consolidation measures applied to health systems should not 
compromise the access of poor, vulnerable populations to high-quality healthcare. 
According to a study of policy responses to the economic crisis,
87 several countries have increased 
user charges for essential services, while in some cases also allowing more income-based 
                                                                                                                                                                                          
82 Devaux M, de Looper M, Income-related inequalities in health service utilisation in 19 OECD countries 
2008-2009, OECD Health working papers 58, 2012. 
83 Citizens from central and eastern Europe, as shown by the FP7 Research Project ASSPRO CEE 2007 
(http://www.assprocee2007.com/), are often confronted with informal patient payments for healthcare 
services. These range from the ex-ante cash payment to the ex-post gift in kind. The causes of informal 
payments need to be tackled for these reforms to be successful and to guarantee equal access to healthcare. 
Vulnerable groups or households with a chronically ill member are less protected against informal payments 
and are most likely to forego treatment or to experience catastrophic, impoverishing effects due to formal and 
informal out-of-pocket payments. 
84 Commission Communication — Annual Growth Survey 2013 — COM(2012) 750 final, 28.11.2012. 
85 Two documents accompanying this package address in particular children, as investments in prevention 
during early childhood are likely to bring substantial benefits over the whole lifespan, and homelessness, as 
health problems are both a triggering factor and a consequence of homelessness. See the Commission 
Recommendation on "Investing in children: breaking the cycle of disadvantage", and the Commission Staff 
Working Document on "Confronting Homelessness in the European Union" adopted as part of this package.. 
86 On the importance of access to quality services, and notably health services, as part of an active inclusion 
strategy, see the Commission Staff Working Document on "the Follow-up on the implementation by Member 
States of the 2008 European Commission recommendation on active inclusion of people excluded from the 
labour market" adopted as part of this package. 
87 Philipa Mladovsky et al. (2012), Health policy responses to the financial crisis in Europe, WHO Policy 
Summary 5. http://www.euro.who.int/__data/assets/pdf_file/0009/170865/e96643.pdf.  
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exemptions.
88  Given that vulnerable populations are already disproportionately affected by the 
economic crisis and that ill health has negative outcomes on employability, possible effects on those 
populations should be carefully assessed. Healthcare coverage can help reduce poverty. Measures 
such as those that increase co-payments risk aggravating the economic hardship borne by vulnerable 
populations by reducing access to healthcare.
89  
Increasing knowledge of the effects of healthcare coverage on poverty, as measured at household 
level, should take the following into account. 
•  Evidence suggesting that a large amount of total spending on healthcare during a person’s life 
is concentrated in the final year(s) of life.
90   Health expenditure comparisons between 
individuals would therefore ideally be based on lifetime analyses and not be limited to a given 
year. 
•  The inherent complexity of interactions among several causal factors and variables, such as 
the likelihood of similarity in the socio-economic backgrounds of spouses and feedback loops 
in causal pathways between health and poverty. 
 
Good practice example — analysis of the redistributive impact of public health expenditure 
A 2011 paper by Spadaro et al.
91 shows how data collected for the Eurostat Survey of Income and 
Living Conditions (SILC) can be used to analyse the redistributive impact of public health expenditure 
in Spain. This is done using an insurance value approach to take account of the effect of healthcare 
expenditure on household budgets. The equivalent household income complemented by public 
healthcare coverage is assessed and compared with household disposable income. It is found that 
public healthcare coverage is likely to keep families out of poverty. Extending the analysis to 
incorporate the household income foregone due to healthcare-related tax transfers would allow the net 
impact of public healthcare coverage to be estimated in terms of the percentage of poverty avoided. 
This could be calculated as the added number of covered residents that would fall below a given 
poverty threshold in the hypothetical absence of healthcare coverage. 
Spain recently introduced reforms of its co-payment system for medicines.  The reforms take into 
account the redistributive impact of the co-payment system by linking it to the level of income, thus 
making it more progressive. 
The Commission will continue to support measures to address health inequalities within and between 
Member States by implementing the 2009 Communication Solidarity in Health: Reducing Health 
                                                            
88 This is however unlikely to lead to substantial savings in budgets as health spending is concentrated on a 
section of the population that does not necessarily overlap with the poorest section (lowest income quintile), 
and protects against catastrophic health expenditure (the inability of individuals to pay for healthcare services 
— in itself not necessarily synonymous with high healthcare costs). This suggests that income-based 
exemptions should be coupled with co-payment ceilings. 
89 HOPE, the European Hospital and Healthcare Federation reports a marked increase in emergency services 
activities and longer waiting time and waiting lists. 
http://www.hope.be/05eventsandpublications/docpublications/86_crisis/86_HOPE-
The_Crisis_Hospitals_Healthcare_April_2011.pdf. 
90 Commission, 2009 Ageing report, Economic and budgetary projections for the EU-27 Member States 
2008-2060. http://ec.europa.eu/economy_finance/publications/publication14992_en.pdf. 
91 http://www.ief.es/documentos/investigacion/seminarios/economia_publica/2011_18MayoPPT.pdf.  
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Inequalities in the EU.
92 It plans to increase knowledge and evidence to facilitate the exchange of best 
practice and share understanding of the effects of health investments on social exclusion and poverty 
reduction. This must include tackling the methodological difficulty of valuing benefits in kind. 
4.   European financial instruments for investing in health  
As a follow-up to the current EU  Health Programme, and as part of the Multiannual Financial 
Framework 2014–20, the Commission put forward a proposal for a new Health Programme. It 
strengthens the link between economic growth and a healthy population and is geared towards 
measures in line with the Europe 2020 objectives. The programme has four objectives: 
•  to contribute to innovative and sustainable health systems; 
•  to increase access to better and safer healthcare for all EU citizens; 
•  to promote good health and prevent diseases by addressing the risk factors of most 
diseases; 
•  to protect people from cross-border health threats.   
The EU’s Cohesion Policy and its funds
93 are also powerful instruments to help Member States 
invest in sustainable, innovative and reformed health systems, in people’s health for employability and 
in reducing health inequalities. The Member States allocated over five billion euro on health 
infrastructure from 2007 to 2013. Using structural funds for non-direct health investments such as 
urban regeneration, transport, environment, employment, social inclusion and housing can also have 
positive impacts on  population’s health.
94 
The Commission proposals for the next programming period (2014–2020) provide for the support of 
the Cohesion and Structural Funds to the Member States’ investments in health. Health is also 
included in most of the thematic objectives of the Common Strategic Framework.
95 The EU Cohesion 
and Structural Funds should co-finance investments in health by the Member States that follow a 
coherent, strategic policy approach by 
•  investing in health infrastructure that fosters a transformational change in the health system, in 
particular reinforcing the shift from a hospital-centred model to community-based care and 
integrated services; 
•  improving access to affordable, sustainable and high-quality healthcare, in particular with a 
view to reducing health inequalities between regions and giving disadvantaged groups and 
marginalised communities better access to healthcare; 
•  supporting the adaptation, up-skilling and life-long learning of the health workforce; 
                                                            
92 COM(2009) 567 final. The Communication is implemented in particular through a Joint Action supported 
by the Health Programme: http://ec.europa.eu/eahc/projects/database.html?prjno=20102203. A progress 
report on the implementation of the Communication is to be published in 2013. 
93 For the specific role of the European Social Fund, see European Commission Staff Working Document - 
Social investment through the European Social Fund, SWD(2013) 44, adopted as part of this package. 
94 For more information on health gains through structural funds see  http://www.healthgain.eu/  
95 Commission proposal for a regulation laying down common provisions and creating a common strategic 
framework, in particular Annex IV — COM(2011) 615 final/2, 2011/0276 (COD).  
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•  fostering active, healthy ageing to promote employability and employment and enable people 
to stay active for longer. 
The Seventh Framework Programme  and the EU programme for research and innovation for 2014 to 
2020 (Horizon 2020)
96 also provide financial opportunities to address the societal challenge of an 
ageing population and harness innovation in public health and the management of health systems. 
Conclusion 
Getting more value for money through reforms and investments is crucial. Investing in health can lead 
to smarter spending — not more spending — that brings savings or secures better health outcomes. It 
may take different forms, such as change in the management of care to improve efficiency while 
improving health outcomes, investment in healthcare staff, training or equipment and initiatives to 
promote good health and prevent diseases.. The avoidable morbidity and mortality underlying health 
inequalities represent a waste of human capital that must be reduced. 
Universal access to safe, high-quality, efficient healthcare services, better cooperation between social 
and healthcare services and effective public health policies to prevent chronic disease can make an 
important contribution to economic productivity and social inclusion. Reforms complemented by the 
above mentioned targeted investments should foster cost-effective innovation to achieve good health 
outcomes and aim to avoid increasing disease and financial burdens in the long term. Financial 
consolidation and structural reform of health systems must go hand in hand to continue 
delivering on public policy goals and ensure that efficiency gains will guarantee universal access 
and increase the quality of healthcare. They should be addressed as part of the wider agenda of 
structural reforms within the context of Europe 2020 and the European Semester.   
                                                            
96  Proposal for a Regulation of the European Parliament and Council establishing Horizon 2020 — the 
Framework Programme for Research and Innovation (2014–20), COM(2011) 809 final. 